Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside.

International journal of molecular sciences - 26 Apr 2020

Solimando Antonio G, Crudele Lucilla, Leone Patrizia, Argentiero Antonella, Guarascio Matteo, Silvestris Nicola, Vacca Angelo, Racanelli Vito

Abstract excerpt

: Immune checkpoint inhibitor (ICI)-related inflammatory diseases, including polymyositis (PM) and dermatomyositis (DM), in patients suffering from neoplastic disorders represent a medical challenge. The treatment of these conditions has taken on new urgency due to the successful and broad development of cancer-directed immunological-based therapeutic strategies. While primary and secondary PM/DM phenotypes have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Myositis

Share to Neoplasms

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 32357515
DOI: 10.3390/ijms21093054
PMCID: PMC7246673

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside.PMID 32357515Read ↗

Bridging clinical phenotypes with molecular mechanisms in autoimmune irAEs: An Etiopathogenic framework.Semantic proximity Read ↗

Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositisSemantic proximity Read ↗

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositisSemantic proximity Read ↗

Myositis-specific autoantibodies and their clinical associations in Idiopathic Inflammatory MyopathiesSemantic proximity Read ↗

Distinct Cytokine and Cytokine Receptor Expression Patterns Characterize Different Forms of MyositisSemantic proximity Read ↗

Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Semantic proximity Read ↗

Analysis of the Potential Link Between Dermatomyositis and CancerSemantic proximity Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Reveal the biomarkers and immune infiltration of dermatomyositis and explore associated diseases as well as drug molecules by bioinformatics analysisSemantic proximity Read ↗

Cytotoxic and regulatory CD8 T cells dynamics underlies ICI-myotoxicity outcomeSemantic proximity Read ↗

Anti-melanoma-associated Antigen A1 Autoantibodies Predict the Outcome of Patients With Idiopathic Inflammatory Myopathies Related Interstitial Lung DiseaseSemantic proximity Read ↗

The pathogenesis of dermatomyositis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.